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Abstract
Background: Currently in Vietnam contact tracing for multidrug-resistant tuberculosis (MDR-TB) entails passive case
finding among symptomatic household contacts who present themselves for diagnosis. Close contacts of MDR-TB
cases are therefore not identified adequately. We assessed the added value of active contact tracing within and
beyond households using social network questionnaires to identify close contacts of MDR-TB patients in Vietnam.
Methods: We conducted a cohort study using social network questionnaires in which contacts were identified by
MDR-TB patients, including contacts from ‘high risk’ places like work. Contacts of MDR-TB patients were followed up
and screened over a period of at least 6 months. This included two active screenings and any unscheduled passive
screening of self-referred contacts during the study period.
Results: Four hundred seventeen contacts of 99 index cases were recruited, 325 (77.9%) and 160/417 (38.4%)
contacts participated in the first and second screenings, respectively. The first screening detected one TB case but
the bacteria were not MDR. From passive screening, a household contact was diagnosed with TB meningitis but
not through our active approach.
Social network analysis showed that only 1/17 (5.9%) high-risk places agreed to cooperate and were included in the
screening, and no MDR-TB cases were detected. There were two pairs of index cases (identified separately) who
were found to be contacts of each other and who had been diagnosed before the study started.
Conclusions: No new MDR-TB cases were detected using social network analysis of nearly 100 MDR-TB index cases,
likely due to a relatively short follow up time, and loss to follow up (lack of cooperation from contacts or high risk
places and lack of available resources in the National Tuberculosis Control Programme).
Keywords: Multi drug resistance tuberculosis, Contact tracing, Vietnam
Background
The emergence of resistance to anti-tuberculosis drugs,
and particularly of multidrug-resistant tuberculosis
(MDR-TB) is a serious public health threat and an obs-
tacle to effective global TB control [1]. It is crucial to
identify more MDR-TB cases at an earlier stage and pro-
vide optimal treatment. Vietnam is ranked 13th among
30 high burden MDR-TB countries (based on estimated
incidence by absolute number) with an estimated 5500
MDR-TB among a total of 100.000 notified TB cases per
year [2]. Despite the efforts to utilize rapid test to inten-
sify case finding of MDR-TB; in Vietnam, the proportion
of MDR-TB cases detected and treated annually is low
compared with the estimated number of incident
MDR-TB cases (less than 50%, see Additional file 1 for
notification and enrollment of MDR-TB cases) [3].
Contact screening of MDR-TB patients is highly rec-
ommended by the World Health Organization (WHO)
[4]. However, contact investigation of household mem-
bers only is not sufficient to identify all MDR-TB cases
due to transmission outside the household. In rural
Vietnam only 1% of index TB patients had a positive
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household member and 83% of these household TB
cases were infected with an isolate that differed from
that of their household members [5]. These results are
similar to those in higher incidence settings in South Af-
rica, and Malawi [6, 7]. The WHO also recommends to
conduct contact investigation beyond the household for
patients with MDR-TB and extensively drug-resistant
TB (XDR-TB), and to collect additional information re-
garding their residence and other social settings where
transmission may have occurred such as hotels, shelters
and bars [4]. Contact tracing using social network ques-
tionnaires is a more comprehensive approach than
household contact tracing, which includes the linking
person to person or person to place for contact investi-
gation [8, 9].
Although screening of close contacts of MDR-TB pa-
tients is recommended by the National Tuberculosis
Control Programme (NTP) of Vietnam (see Additional
file 1 for policy recommended by the NTP Guidelines)
[10], there is no system in place to support this. Cur-
rently a passive case finding approach is used, where
household contacts are advised to seek TB diagnosis
when symptomatic.
We assessed the added value of active contact tracing
within and beyond the household using social network
questionnaires (SNQ) among contacts of MDR-TB pa-
tients in Vietnam.
Methods
Study design and setting
A cohort study was conducted to analyze the added value
of an active screening using SNQ, the questionnaire re-
vealed the patient’s contacts through their social network
including the frequently met people and visited places.
Contacts were either named by patients or identified from
eligible places. Close contacts of MDR-TB patients were
enrolled and followed up over a period of at least 6
months and screened for TB and MDR-TB. Contacts were
screened at enrolment, followed by an appointment on
completion of the first screening and a reminder at 6
months by telephone for the second screening. During the
study period, study participants were asked to make an
unscheduled visit to district TB units and contact with the
district health coordinators if they had any symptom sug-
gestive of TB. The screening consisted of (i) standardized
clinical assessment, (ii) chest X-ray among those who were
not presumed to have TB by clinical assessment, and (iii)
microbiological testing by Gene Xpert MTB/RIF (Xpert,
Cepheid, the United States) for patients with a history or
chest X-ray suggestive of TB.
Study population and definitions
The study involved patients with rifampicin resistant
TB and their eligible contacts (all ages), who were
named by index patients or identified from eligible
places as defined below. The minimum sample size
was estimated at 100 patients (see Additional file 2
for sample size calculation).
Inclusion criteria
Eligible for enrolment were all patients diagnosed with
rifampicin-resistant TB or MDR-TB diagnosed by Xpert
or by Genotype MTBDR Plus Line Probe Assay (Hain
Lifescience Nehren, Germany) who were living in Hanoi
and started MDR-TB treatment between October 2013
and April 2015. Their defined contacts (household con-
tacts or contacts outside the household, either named by
patients or from eligible places) during the 3 months pre-
ceding MDR-TB diagnosis were eligible for enrolment as
contacts. Eligible high-risk places were physically enclosed
spaces where the MDR-TB index case spent an average of
at least 4 h a day for at least 14 days, or a cumulative total
average duration of at least 8 h per week for at least 8
weeks in 3 months prior MDR-TB diagnosis. For children
who were less than 18 years old, information was obtained
from their parents or responsible family members.
Data collection and analysis
We modified and contextualized a published case report
form (CRF) [11], which was then validated by fine tuning
the language to make sure the respondents can under-
stand and answer our questions adequately, and used to
interview consenting patients (see Additional file 2 for
description of modifications to the questionnaire). The
following data were collected: demographics, medical
history, social network including their contacts and fre-
quently visited places, as well as tracing information
(name, address, telephone number). As soon as patients
were diagnosed and enrolled for treatment during one to
two weeks at the provincial hospital, informed consent
was obtained, and the interviews with the patients were
conducted by trained TB health care workers. Com-
pleted patient CRFs were entered in a central database
(CliRes) and reviewed by the study coordinator to iden-
tify eligible places and contacts (see Additional file 2 for
operational definitions) for screening.
Eligible contacts were registered at district TB units to
be followed up by the study team. Eligible places were vis-
ited by provincial or district coordinators to obtain in-
formed consent from the place’s legal representative,
followed by public announcement to call frequent visitors
to come for screening to identify additional contacts. Com-
pleted contact CRFs were entered in the central database.
Social network analysis was applied to identify links
among MDR-TB index cases, contacts, and places. In
the network illustrated by the link among patients, con-
tacts and places, contacts or index cases linked to more
than one patient were considered as the source of
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transmission, hence the centers of the network. The cen-
trality degree of the contacts was measured by the num-
ber of patients attached with each contact. In order to
determine if the contacts or places were mutual (i.e.
named by at least 2 confirmed MDR-TB patients),
demographics and information such as address and tele-
phone number of the places and contacts were collected
and compared. Mutual contacts or places were identified
when identical information was obtained between pairs of
contacts or pairs of places named by different patients.
The Social network analysis also looked at the density il-
lustrated by how closely contacts and patients are con-
nected. The number of contacts per patient was used to
rank the closeness level between patient and contacts [12].
Statistical analysis
Data were entered in MS Access software (Microsoft
Inc., USA) and then transferred to SPSS 16.0 for statis-
tical analysis. Descriptive statistics, including frequency,
median, interquartile range (IQR), proportion and 95%
confidence intervals (95% CIs), were performed where
appropriate. The comparisons were tested statistically
using Chi-Square test to compare proportions. P-values
(2-sided) below 0.05 were considered significant.
Results
Characteristic of MDR-TB patients (index cases)
Of 112 eligible patients, 99 were enrolled into the study
as MDR-TB index cases. All patients were adult,
51(51%) were 35–54 years old and 77 (78%) were male.
Four patients were HIV positive (Table 1).
Sputum smear and chest X-ray were performed for all
patients: 76/99 (77%) had a smear- positive result.
Thirty-two patients (32%) had X-ray signs of cavitation, all
of whom were smear-positive. Seventy patients (71%) had
been previously treated with first-line anti-TB drugs.
These included patients detected as MDR-TB when start-
ing retreatment or detected later when found to be
smear-positive (non-converters) after two months of
retreatment. Fourteen patients (14%) had received no or
less than one month of TB treatment previously. The
remaining 15 patients (15%) included 11 non-converters
during their first treatment course and 4 patients previ-
ously treated in the private sector with unknown outcome.
Characteristics of contacts
We identified 496 contacts and 17 high risk places based
on information provided in the SNQ: 481 contacts were
named by patients and 17 high risk places were
approached by visiting for informed consent. Of which 1
place agreed to cooperate and subsequently an add-
itional 15 contacts were identified.
Seventy-nine contacts were excluded from the study
because they were not living in Hanoi (n = 16) and/or
had not been in direct contact with the index patient
during the 3 months before diagnosis (n = 69) (Fig. 1),
leaving 417 eligible contacts whose characteristics are
described in Table 2. They included 292 (70.0%) house-
hold contacts and 125 (30.0%) non-household contacts.
Of the 125 non-household contacts, one contact came
from a high-risk place, and the others had been named
by index patients. Of the 417 eligible contacts, 189
(45.3%) were males and 86 (20.6%) were children under
15 years of age at the time of identification.
Table 1 Characteristics of patients at baseline
n %
Total patients 99 100
Characteristic
Age group
0–14 years 0 0
15–24 years 14 14
25–34 years 15 15
35–44 years 28 28
45–54 years 23 23
55–64 years 14 14
65 year and above 5 5
Median age 43
Mean age (sd) 42.3 (13.9)
Gender
Male 77 78
Female 22 22
HIV (+) 4 4
Sputum smear
Negative 23 23
Positive 76 77
Grade among smear positivea
Scanty 20 26
1+ 33 43
2+ 13 17
3+ 10 13
Chest X-ray
Cavity 32 32
Patient categoryb
New 14 14
Non-converters of first line drug for new cases 11 11
Non-converters of first line drug for
retreatment cases
1 1
Previously treated cases 69 70
Others 4 4
aBased on the International Union Against Tuberculosis and Lung Disease
(IUATLD)-recommended grading of sputum smear microscopy results (n = 76)
bRefer to Additional file 2 for definition of patient category
Hoang et al. BMC Public Health          (2019) 19:241 Page 3 of 8
Screening practices
Of the 417 eligible contacts, 325 (77.9%) participated in
the first screening (Fig. 1). Of the remaining 92 contacts,
70 could not be traced and 22 refused (including 3
household and 19 non- household contacts). 160
participated in the second screening including 137 who
had also been screened in the first screening. The
remaining 188 contacts refused to be screened for sec-
ond time. The proportions of household contacts and
non-household contacts participating in the first screen-
ing were 248/292 (84.9%) and 77/125 (61.6%) respect-
ively. The proportions were lower in the second
screening: 127/292 (43.5%, p < 0.001) and 33/125 (26.4%,
p < 0.001), respectively. The participation of female con-
tacts in the first screening was higher than for males,
186/223 (83.4%) versus 135/189 (71.4%; p = 0.004) (see
Additional file 2 for more detailed table). There were
no apparent differences in the proportion of contacts
participating in the screening by age group (see Add-
itional file 2).
Upon first screening 36/325 (11.1%) contacts inter-
viewed were clinically diagnosed as presumed TB. Chest
X-rays were performed for 299 contacts, including 10 with
clinically presumed TB, of whom an additional 12 (4.0%)
had an abnormal chest X-ray suggestive for TB (Fig. 1).
Xpert testing was performed for the total of 48 presumed
TB cases identified by clinical assessment and/or by chest
X-ray. We detected one drug-susceptible TB case and no
rifampicin-resistant/MDR-TB case from the first active
screening of contacts (Fig. 2).
Among 160 contacts assessed in the second active
screening, twenty-seven (including 3 contacts who also
participated in the first screening) had presumptive TB
by interview and/or chest X-ray. Xpert MTB/RIF testing
detected no TB case. From passive screening, a two-year
old child, whose father was an index patient, was
Fig. 1 Flow chart of TB screening practice (part A)
Table 2 Characteristics of MDR-TB contacts
Characteristic n %
Total contacts 417
Age group
0–14 years 86 20.6
15–24 years 65 15.6
25–34 years 65 15.6
35–44 years 67 16.1
45–54 years 49 11.8
55–64 years 50 12.0
65 year and above 27 6.5
Missing 8 1.9
Median age 32
Mean age (sd) 34.0 (20.0)
Gender
Male 189 45.3
Female 223 53.5
Missing 5 1.2
Type of contact
Household contact 292 70.0
Non-household contacts 125 30.0
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diagnosed with TB meningitis but not as part of our
study (Fig. 2). This child was not identified as presumed
TB in the first screening. She was taken by her parents
to the Vietnam national children hospital for diagnosis
and not to the district coordinator when later having
fever, cough and loss of consciousness.
Social network analysis
The median number of eligible contacts per index pa-
tient was 3 (IQR: 3–6). These median numbers were 3
(IQR: 2–4) among household contacts and 2 (IQR: 1–4)
among non-household contacts. Index patients named
35 places, of which 17 were identified as high-risk
places including 3 workplaces (1 vocational school, 1
private tailoring company, 1 grocery store), 3 internet
café’s, 2 hair salons and 9 restaurants. Only 1/17 (5.9%)
high-risk place (vocational school) agreed to cooperate.
One presumed MDR-TB case was identified based on
clinical diagnosis among 15 people screened who fre-
quented this high-risk place (Fig. 1) but not diagnosed
as TB. We found no mutual contact and no mutual
place among the MDR-TB index cases. Two additional
TB cases were detected among household contacts (in-
cluding the confirmed drug-susceptible case and the
child with unknown drug resistance status). Moreover,
two pairs of index cases (four patients) were found to
be contacts of each other (diagnosed before study
started; Fig. 3). No genotyping was done to look at gen-
etic relatedness.
Discussion
We conducted social network analysis to be able to de-
tect more MDR-TB cases than through passive case
finding. Enrolling 99 MDR-TB cases and their contacts
did not reveal new MDR-TB cases. One child with
(probable) MDR-TB meningitis was missed by our study.
Links between MDR-TB cases were found in two in-
stances but did not lead to the detection of new cases.
Only one of seventeen high-risk places agreed to partici-
pate in the screening, resulting in one additional pre-
sumed MDR-TB case identified.
The likely reasons why we did not detect additional
MDR-TB cases was limited participation of contacts in
TB screening. Participation was reasonable (~ 80%) in
the first screening, but dropped considerably to ~ 40% at
the second screening. Observation from discussions with
staff suggest that participation may have been poor due
to the following elements:1) perceived stigma among pa-
tients, contacts and high risk places and reluctance to
cooperate and to reveal correct contact information, 2)
low awareness about TB and its transmission, especially
among contacts with low levels of education or contacts
belonging to vulnerable groups such as drug users, and
3) participation in the second screening may not have
been perceived as in their interest if they were busy and
not diagnosed with TB from the first screening.
Furthermore, the relatively short follow-up period in
our study of 6 months may be another reason. Studies
have shown that active TB usually develops within five
years after initial infection [13–15], and predominantly
Fig. 2 Flow chart of TB screening practice (part B). TB+/R(+): MTB detected with Rifampicin resistance. TB+/R(−): MTB detected without Rifampicin
resistance. HH: Household contact
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(45%) especially in the first year [16]. The median time
from infection to symptoms in secondary cases is esti-
mated to be 1.3 years [16]. Household contacts of
MDR-TB patients are considered to be at higher risk to
get infected than household members of drug-susceptible
TB cases [17, 18]. This is because, even though
MDR-TB isolates are usually less transmissible [19],
family members of MDR-TB cases tend to have been
exposed for a longer duration due to delays in correct
treatment initiation[17, 19]. Therefore, contact investi-
gation is useful for early case detection and treatment
to reduce transmission of MDR-TB [4, 18].
The pick-up rate for MDR-TB cases may also increase
by improving the sensitivity of our diagnostic approach.
Future diagnostic approaches should consider: (i) to en-
sure the quality of sputum and chest X-ray, (ii) expand-
ing TB clinical assessment criteria to any cough and
other tuberculosis-related symptoms like chest pain,
weight loss, lack of appetite, weakness or fatigue, chills,
fever and night sweats (iii) including MTB culture with
higher sensitivity [20] as an add-on test following Xpert
result, (iv) using multiple rather than a single specimen,
to increase the diagnostic yield of Xpert MTB/ RIF [20].
However, resources in low and middle-income countries
(LMICs) are generally limited and therefore it may not
be feasible to implement all these recommendations.
A limitation of our study using Xpert MTB/RIF is that
only TB and rifampicin resistance is diagnosed as an in-
dicator for MDR-TB [20]. In Vietnam we generally also
perform culture and additional sensitivity testing of
drugs included in first and second line regimens to con-
firm MDR-TB and tailor treatment.
There is a need to develop a system to identify and
manage contacts of MDR-TB cases better, including pro-
viding of adequate instructions, and possibly screening.
We recommend to use a simpler questionnaire rather
than a comprehensive social network approach. This is a
more efficient and likely more cost-effective means for
MDR-TB case detection in Vietnam and other low and
middle-income countries. Information about household
contacts and those who have the most frequent contact
with patients such as close friends and colleagues should
be collected. Depending on available resources, screen-
ing may start with a clinical assessment to determine if
Fig. 3 Social network of MDR-TB cases with identified links among index cases and TB cases detected among contacts
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the person has TB-related symptoms, followed by chest
X-ray and Gene Xpert MTB/RIF. This should be com-
bined with health education, i.e. inform contacts with
what symptoms they need to come for TB screening.
Health education about TB, MDR-TB and its transmis-
sion among the general population should be more fo-
cused, and results of this study may help in prioritizing
risk groups. It is needed to enhance awareness among
contacts of MDR-TB and their compliance with screening
programmes. Particular attention should be paid to en-
hance screening of non-household contacts as some stud-
ies show the incidence of TB among these contacts to be
higher compared with household contacts [5–7]. Further-
more, we found a lower screening participation of male
contacts in our study, which is in line with findings from
our national prevalence survey. Therefore, more efforts
are needed to find male tuberculosis patients [21].
Currently, about 50% of the estimated MDR-TB cases in
Vietnam have not been previously treated, reflecting sig-
nificant transmission of MDR-TB among contacts [20–
24]. However, the routine case finding strategy for detec-
tion of MDR-TB during our study period mainly focused
on previously treated TB cases Additional file 1 [10], with
only 14% of MDR-TB patients diagnosed being
treatment-naive. It is important for Vietnam to pay more
attention to management of MDR-TB among new cases
including close monitoring of MDR-TB contacts. Given
the low yield of MDR-TB case detection from our study,
beyond improving contact investigation, other potential
groups should be considered to address 50% of undetected
MDR-TB burden in Vietnam. Furthermore, diagnostic
screening strategies should be enhanced. Approaches can
be applied depending on the resources available as follows:
microbiological testing by Gene Xpert MTB/RIF for (i) all
newly detected TB patients including smear positive and
negative (ii) presumptive TB cases who had/have contact
with MDR-TB patients. These contacts can be identified
by healthcare workers through interviewing TB presump-
tive cases who come to their health facility for health
check up, and (iii) all TB presumptive.
While MDR-TB can be cured, social barriers to
MDR-TB treatment could be an important factor that
needs to be taken into account when designing and
implementing a contact tracing program [17]. Home
visits by contact investigators are an effective method for
interviewing household contacts and encouraging them
to be assessed for TB [4]. By visiting index patients and
their household contacts, the investigator is able to ob-
serve the housing conditions, perform an environmental
assessment for infection control measures, and discuss
and evaluate the risk of exposure, as well as provide
counseling to household contacts on symptoms suggest-
ive of TB and when and where to seek health care and
social support [4].
Even though we did not find any new MDR-TB case
directly through our social network analysis, this ap-
proach may still be worth consideration if the key limita-
tions of our study are addressed. The screening process
should be simplified, well organized, to increase the par-
ticipation of contacts, extend the time of follow-up of
contacts, and improve diagnostic screening strategy.
Given that the low participation rate in our study may
have limited case detection, it is recommended to ex-
pand health education on transmission of TB and
MDR-TB among contacts, reduce stigma attached to
TB, improve communication skills of health staff, and
increase staff resources to trace contacts and get them
involved in the screening.
Conclusion
In this study of nearly 100 MDR-TB index cases we were
not able to find new MDR-TB cases using household
contact screening and social network analysis within a
follow-up period of 6 months. Screening of identified
contacts was complicated by refusals. More staff re-
sources may be needed and better communication skills
and community awareness, collaboration of non NTP
health facilities is needed to enhance participation and
improve MDR-TB case detection.
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